According to new research from Ghent, Belgium, intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be a successful technique in combating antimicrobial resistance. The findings will be presented at ASM Microbe 2023, the American Society for Microbiology's annual meeti
Cisplatin is commonly used as a chemotherapeutic drug in the treatment of many solid tumours, including bladder, ovarian, and esophageal tumours. However, when it is metabolised by an enzyme called "cysteine conjugate beta-lyase 1 (CCBL1)," it is transformed to "thiol-cisplatin," a highly ac
University of Illinois at Chicago researchers have discovered a small molecule that controls an immune process that is crucial in the development of cancer and autoimmune disorders.
Researchers at the University of Illinois Chicago have found a small molecule capable of manipulating an immune process that plays an important role in cancers and autoimmune diseases.